Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 190

1.

SUMO-specific protease 2 mediates leptin-induced fatty acid oxidation in skeletal muscle.

Koo YD, Lee JS, Lee SA, Quaresma PGF, Bhat R, Haynes WG, Park YJ, Kim YB, Chung SS, Park KS.

Metabolism. 2019 Jun;95:27-35. doi: 10.1016/j.metabol.2019.03.004. Epub 2019 Mar 19.

PMID:
30902749
2.

Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice.

Lindén D, Ahnmark A, Pingitore P, Ciociola E, Ahlstedt I, Andréasson AC, Sasidharan K, Madeyski-Bengtson K, Zurek M, Mancina RM, Lindblom A, Bjursell M, Böttcher G, Ståhlman M, Bohlooly-Y M, Haynes WG, Carlsson B, Graham M, Lee R, Murray S, Valenti L, Bhanot S, Åkerblad P, Romeo S.

Mol Metab. 2019 Apr;22:49-61. doi: 10.1016/j.molmet.2019.01.013. Epub 2019 Feb 5.

3.

Modeling human pancreatic beta cell dedifferentiation.

Diedisheim M, Oshima M, Albagli O, Huldt CW, Ahlstedt I, Clausen M, Menon S, Aivazidis A, Andreasson AC, Haynes WG, Marchetti P, Marselli L, Armanet M, Chimienti F, Scharfmann R.

Mol Metab. 2018 Apr;10:74-86. doi: 10.1016/j.molmet.2018.02.002. Epub 2018 Feb 8.

4.

Publisher Correction: Functional coupling of human pancreatic islets and liver spheroids on-a-chip: Towards a novel human ex vivo type 2 diabetes model.

Bauer S, Wennberg Huldt C, Kanebratt KP, Durieux I, Gunne D, Andersson S, Ewart L, Haynes WG, Maschmeyer I, Winter A, Ämmälä C, Marx U, Andersson TB.

Sci Rep. 2018 Jan 23;8(1):1672. doi: 10.1038/s41598-018-20340-1.

5.

Functional coupling of human pancreatic islets and liver spheroids on-a-chip: Towards a novel human ex vivo type 2 diabetes model.

Bauer S, Wennberg Huldt C, Kanebratt KP, Durieux I, Gunne D, Andersson S, Ewart L, Haynes WG, Maschmeyer I, Winter A, Ämmälä C, Marx U, Andersson TB.

Sci Rep. 2017 Nov 6;7(1):14620. doi: 10.1038/s41598-017-14815-w. Erratum in: Sci Rep. 2018 Jan 23;8(1):1672.

6.

Hemoglobin A1c and C-reactive protein are independently associated with blunted nocturnal blood pressure dipping in obesity-related prediabetes.

Lane-Cordova AD, Kalil GZ, Wagner CJ, Sindler AL, Fiedorowicz JG, Ajibewa T, Haynes WG, Pierce GL.

Hypertens Res. 2018 Jan;41(1):33-38. doi: 10.1038/hr.2017.82. Epub 2017 Oct 26.

7.

Higher augmentation index is associated with tension-type headache and migraine in middle-aged/older humans with obesity.

Kalil GZ, Recober A, Hoang-Tienor A, Bridget Zimmerman M, Haynes WG, Pierce GL.

Obesity (Silver Spring). 2016 Apr;24(4):865-70. doi: 10.1002/oby.21414. Epub 2016 Feb 5.

8.

Finger volume pulse waveforms facilitate reliable assessment of heart rate variability, but not blood pressure variability or baroreflex function.

Linder JR, Stauss HM, Gindes H, Pierce GL, Von Bergen NH, Haynes WG, Fiedorowicz JG.

BMC Cardiovasc Disord. 2014 Dec 9;14:180. doi: 10.1186/1471-2261-14-180.

9.

Body fat indices and biomarkers of inflammation: a cross-sectional study with implications for obesity and peri-implant oral health.

Elangovan S, Brogden KA, Dawson DV, Blanchette D, Pagan-Rivera K, Stanford CM, Johnson GK, Recker E, Bowers R, Haynes WG, Avila-Ortiz G.

Int J Oral Maxillofac Implants. 2014 Nov-Dec;29(6):1429-34. doi: 10.11607/jomi.3758.

PMID:
25397806
10.

Effects of antipsychotic drugs on cardiovascular variability in participants with bipolar disorder.

Linder JR, Sodhi SK, Haynes WG, Fiedorowicz JG.

Hum Psychopharmacol. 2014 Mar;29(2):145-51. doi: 10.1002/hup.2380. Epub 2014 Jan 3.

11.

Sodium nitrite in patients with peripheral artery disease and diabetes mellitus: safety, walking distance and endothelial function.

Mohler ER 3rd, Hiatt WR, Gornik HL, Kevil CG, Quyyumi A, Haynes WG, Annex BH.

Vasc Med. 2014 Feb;19(1):9-17. doi: 10.1177/1358863X13515043. Epub 2013 Dec 20.

PMID:
24363302
12.

Association of anxiety with resistance vessel dysfunction in human atherosclerosis.

Stillman AN, Moser DJ, Fiedorowicz J, Robinson HM, Haynes WG.

Psychosom Med. 2013 Jul-Aug;75(6):537-44. doi: 10.1097/PSY.0b013e31829a0ae3. Epub 2013 Jun 20.

13.

Sildenafil increases sympathetically mediated vascular tone in humans.

Dopp JM, Agapitov AV, Sinkey CA, Haynes WG, Phillips BG.

Am J Hypertens. 2013 Jun;26(6):762-9. doi: 10.1093/ajh/hpt018. Epub 2013 Feb 26.

14.

White matter fractional anisotropy is inversely related to anxious symptoms in older adults with atherosclerosis.

Bijanki KR, Stillman AN, Arndt S, Magnotta VA, Fiedorowicz JG, Haynes WG, Matsui JT, Johnson HJ, Moser DJ.

Int J Geriatr Psychiatry. 2013 Oct;28(10):1069-76. doi: 10.1002/gps.3930. Epub 2013 Jan 24.

15.

Acute myocardial infarctions, strokes and influenza: seasonal and pandemic effects.

Foster ED, Cavanaugh JE, Haynes WG, Yang M, Gerke AK, Tang F, Polgreen PM.

Epidemiol Infect. 2013 Apr;141(4):735-44. doi: 10.1017/S0950268812002890. Epub 2013 Jan 3.

16.

Evidence for accelerated vascular aging in bipolar disorder.

Sodhi SK, Linder J, Chenard CA, Miller del D, Haynes WG, Fiedorowicz JG.

J Psychosom Res. 2012 Sep;73(3):175-9. doi: 10.1016/j.jpsychores.2012.06.004. Epub 2012 Jul 4.

17.

Rate of weight gain and cardiometabolic abnormalities in children and adolescents.

Calarge CA, Xie D, Fiedorowicz JG, Burns TL, Haynes WG.

J Pediatr. 2012 Dec;161(6):1010-5. doi: 10.1016/j.jpeds.2012.05.051. Epub 2012 Jun 26.

19.

Systematic Review and Meta-analysis of Pharmacological Interventions for Weight Gain from Antipsychotics and Mood Stabilizers.

Fiedorowicz JG, Miller DD, Bishop JR, Calarge CA, Ellingrod VL, Haynes WG.

Curr Psychiatry Rev. 2012 Feb 1;8(1):25-36.

20.

Screening, diagnosis, and treatment of dyslipidemia among persons with persistent mental illness: a literature review.

Vanderlip ER, Fiedorowicz JG, Haynes WG.

Psychiatr Serv. 2012 Jul;63(7):693-701. doi: 10.1176/appi.ps.201100475. Review.

PMID:
22588231
21.

Vasculopathy related to manic/hypomanic symptom burden and first-generation antipsychotics in a sub-sample from the collaborative depression study.

Fiedorowicz JG, Coryell WH, Rice JP, Warren LL, Haynes WG.

Psychother Psychosom. 2012;81(4):235-43. doi: 10.1159/000334779. Epub 2012 May 11. Erratum in: Psychother Psychosom. 2013;82(4):278.

22.

Membranous nephropathy with renal salt wasting: role of neurohumoral factors in sodium retention.

Hommos M, Sinkey C, Haynes WG, Dixon BS.

Am J Kidney Dis. 2012 Sep;60(3):444-8. doi: 10.1053/j.ajkd.2012.02.333. Epub 2012 Apr 18.

PMID:
22516683
23.

Vascular function is not impaired early in the course of bipolar disorder.

Murray DP, Metz NS, Haynes WG, Fiedorowicz JG.

J Psychosom Res. 2012 Mar;72(3):195-8. doi: 10.1016/j.jpsychores.2011.12.006. Epub 2012 Jan 11.

24.

Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications.

Kalil GZ, Haynes WG.

Hypertens Res. 2012 Jan;35(1):4-16. doi: 10.1038/hr.2011.173. Epub 2011 Nov 3. Review.

25.

Factors associated with the prescribing of olanzapine, quetiapine, and risperidone in patients with bipolar and related affective disorders.

Prabhakar M, Haynes WG, Coryell WH, Chrischilles EA, Miller del D, Arndt S, Ellingrod VL, Warren L, Fiedorowicz JG.

Pharmacotherapy. 2011 Aug;31(8):806-12. doi: 10.1592/phco.31.8.806.

26.
27.

Gender differences in neuropsychological performance in individuals with atherosclerosis: impact of vascular function.

Moore CS, Miller IN, Andersen RL, Arndt S, Haynes WG, Moser DJ.

J Clin Exp Neuropsychol. 2011 Jan;33(1):9-16. doi: 10.1080/13803391003757841. Epub 2010 May 28.

28.

Direct control of peripheral lipid deposition by CNS GLP-1 receptor signaling is mediated by the sympathetic nervous system and blunted in diet-induced obesity.

Nogueiras R, Pérez-Tilve D, Veyrat-Durebex C, Morgan DA, Varela L, Haynes WG, Patterson JT, Disse E, Pfluger PT, López M, Woods SC, DiMarchi R, Diéguez C, Rahmouni K, Rohner-Jeanrenaud F, Tschöp MH.

J Neurosci. 2009 May 6;29(18):5916-25. doi: 10.1523/JNEUROSCI.5977-08.2009.

29.

Hypothalamic ERK mediates the anorectic and thermogenic sympathetic effects of leptin.

Rahmouni K, Sigmund CD, Haynes WG, Mark AL.

Diabetes. 2009 Mar;58(3):536-42. doi: 10.2337/db08-0822. Epub 2008 Dec 9.

30.

Dissociation between sympathetic nerve traffic and sympathetically mediated vascular tone in normotensive human obesity.

Agapitov AV, Correia ML, Sinkey CA, Haynes WG.

Hypertension. 2008 Oct;52(4):687-95. doi: 10.1161/HYPERTENSIONAHA.107.109603. Epub 2008 Aug 11.

31.

Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder.

Fiedorowicz JG, Palagummi NM, Forman-Hoffman VL, Miller DD, Haynes WG.

Ann Clin Psychiatry. 2008 Jul-Sep;20(3):131-7. doi: 10.1080/10401230802177722.

32.

Vascular smooth muscle function is associated with initiation and processing speed in patients with atherosclerotic vascular disease.

Moser DJ, Miller IN, Hoth KF, Correia M, Arndt S, Haynes WG.

J Int Neuropsychol Soc. 2008 Jul;14(4):535-41. doi: 10.1017/S1355617708080697.

33.

NPY5R antagonism does not augment the weight loss efficacy of orlistat or sibutramine.

Erondu N, Addy C, Lu K, Mallick M, Musser B, Gantz I, Proietto J, Astrup A, Toubro S, Rissannen AM, Tonstad S, Haynes WG, Gottesdiener KM, Kaufman KD, Amatruda JM, Heymsfield SB.

Obesity (Silver Spring). 2007 Aug;15(8):2027-42.

34.

Arterial compliance and endothelial function.

Correia ML, Haynes WG.

Curr Diab Rep. 2007 Aug;7(4):269-75. Review.

PMID:
17686402
35.

Haemodynamic and renal effects of endothelin receptor antagonism in patients with chronic kidney disease.

Dhaun N, Ferro CJ, Davenport AP, Haynes WG, Goddard J, Webb DJ.

Nephrol Dial Transplant. 2007 Nov;22(11):3228-34. Epub 2007 Jun 7.

PMID:
17556408
36.

LDL cholesteryl oleate: a biomarker for atherosclerosis?

Spector AA, Haynes WG.

Arterioscler Thromb Vasc Biol. 2007 Jun;27(6):1228-30. No abstract available.

PMID:
17522395
37.

Obesity impairs vascular relaxation in human subjects: hyperglycemia exaggerates adrenergic vasoconstriction arterial dysfunction in obesity and diabetes.

Sivitz WI, Wayson SM, Bayless ML, Sinkey CA, Haynes WG.

J Diabetes Complications. 2007 May-Jun;21(3):149-57.

PMID:
17493547
38.

Impairments in microvascular reactivity are related to organ failure in human sepsis.

Doerschug KC, Delsing AS, Schmidt GA, Haynes WG.

Am J Physiol Heart Circ Physiol. 2007 Aug;293(2):H1065-71. Epub 2007 May 4.

39.

Predictors of subjective cognitive difficulties in older adults with atherosclerotic vascular disease.

Humphreys CT, Moser DJ, Hynes SM, Reese RL, Haynes WG.

Am J Geriatr Psychiatry. 2007 Apr;15(4):328-34.

PMID:
17384315
40.

What is the most appropriate methodology for detection of conduit artery endothelial dysfunction?

Guthikonda S, Sinkey CA, Haynes WG.

Arterioscler Thromb Vasc Biol. 2007 May;27(5):1172-6. Epub 2007 Feb 15.

PMID:
17303783
41.
42.

Neuropsychological performance is associated with vascular function in patients with atherosclerotic vascular disease.

Moser DJ, Robinson RG, Hynes SM, Reese RL, Arndt S, Paulsen JS, Haynes WG.

Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):141-6. Epub 2006 Oct 26.

PMID:
17068287
43.

Obesity and insulin resistance but not hyperandrogenism mediates vascular dysfunction in women with polycystic ovary syndrome.

Dokras A, Jagasia DH, Maifeld M, Sinkey CA, VanVoorhis BJ, Haynes WG.

Fertil Steril. 2006 Dec;86(6):1702-9. Epub 2006 Oct 24.

PMID:
17067587
44.

A role for plasminogen activator inhibitor-1 in obesity: from pie to PAI?

Correia ML, Haynes WG.

Arterioscler Thromb Vasc Biol. 2006 Oct;26(10):2183-5. Review. No abstract available.

PMID:
16990563
45.

Antecedent hypoglycemia, catecholamine depletion, and subsequent sympathetic neural responses.

Herlein JA, Morgan DA, Phillips BG, Haynes WG, Sivitz WI.

Endocrinology. 2006 Jun;147(6):2781-8. Epub 2006 Mar 9.

PMID:
16527844
46.

Homocysteine: role and implications in atherosclerosis.

Guthikonda S, Haynes WG.

Curr Atheroscler Rep. 2006 Mar;8(2):100-6. Review.

PMID:
16510043
47.

Role of leptin in obesity-related hypertension.

Haynes WG.

Exp Physiol. 2005 Sep;90(5):683-8. Epub 2005 Aug 16. Review.

48.

Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelines.

Correia ML, Haynes WG.

Expert Opin Emerg Drugs. 2005 Aug;10(3):643-60. Review.

PMID:
16083333
49.

Dietary and medical therapy of obesity.

Stumbo P, Hemingway D, Haynes WG.

Surg Clin North Am. 2005 Aug;85(4):703-23, vi. Review.

PMID:
16061081
50.

Lack of dilator effect of leptin in the hindlimb vascular bed of conscious rats.

Rahmouni K, Jalali A, Morgan DA, Haynes WG.

Eur J Pharmacol. 2005 Aug 22;518(2-3):175-81.

PMID:
16054621

Supplemental Content

Loading ...
Support Center